Myonex closes Creapharm acquisition expanding global services

2 May 2024

Horsham, PA, USA May 2, 2024 Myonex has completed the previously announced acquisition of
CREAPHARM’s pharmaceutical services business . This transaction combines capabilities and flexibility
to serve pharmaceutical and biotech companies in both clinical and commercial stages , including
companies managing Advanced Therapies. Creapharm’s clinical packaging and distribution services,
commercial packaging operations and bioservices will now be known as Creapharm, a Myonex
company. To know more